<DOC>
	<DOCNO>NCT02313922</DOCNO>
	<brief_summary>The purpose study evaluate whether etanercept combine methotrexate superiority etanercept monotherapy treatment chinese severe plaque psoriasis . A phase IV , multicenter , randomize , double-blind , control trial conducted.The primary outcome Change baseline plaque psoriasis assess PASI ( psoriasis area severity index ) response PASI75 ( patient improvement baseline PASI least 75 % )</brief_summary>
	<brief_title>Optimizing Psoriasis Treatment Etanercept Combined Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Adults sex , least 18 year age stable plaque psoriasis least 6 month , psoriasis involve least 10 percent body surface area , minimal PASI 10 screen previously receive phototherapy systemic psoriasis therapy least candidate therapy opinion investigator Patients guttate , erythrodermic , pustular psoriasis time screen recent infection opportunistic infection , active tuberculosis , hepatitis B liver kidney dysfunction serious , progressive , uncontrolled disorder vital organ system ( include cardiovascular , liver , lung kidney ) , autoimmune disease , cancer , HIV infection , suitable participation study disease history significant methotrexate toxicity total cumulative methotrexate exposure &gt; 1000 mg ( unless grade ‡ IIIb liver injury occur ) use ultraviolet ( UV ) B therapy , topical ciclosporin calcineurin inhibitor , class III VII topical corticosteroid ( permit scalp , axilla , ⁄or groin ) , topical vitamin A D analogue within 14 day screen psoralen UVA therapy , systemic psoriasis therapy ( include methotrexate ) , oral retinoids , class I II topical corticosteroid , dithranol , cyclophosphamide , sulfasalazine , intravenous oral calcineurin inhibitor within 28 day screen Patients exclude received tumor necrosis factor ( TNF ) block agent biologics within 3 month interleukin ( IL ) 12 IL23 inhibitor within 6 month study initiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>